Objective: Despite the recent advances in imaging methods, 10-20% is still insufficient in predicting the pathology of renal masses. Therefore, we aimed to examine whether hematological inflammatory markers are useful in predicting pathology outcome.
Method: 116 patients who were operated for kidney mass between January 2010 and October 2020 were included in the study. Retrospectively, preoperative platelets, neutrophils, lymphocytes and their rates were compared with pathology results.
Results: The mean age of 116 patients included in the study was 55.36 ± 13.93. Pathology results of 26 (22.4%) patients were benign and 90 (77.6%) of them were malignant. According to the results of the study, the neutrophil and neutrophil lymphocyte ratio was significantly lower in the benign group. According to the Fuhrman grade of renal cell carcinoma, platelet and platelet lymphocyte ratio was higher in aggressive groups, while lymphocyte count was lower.
Conclusion: Hematological inflammatory markers are useful in predicting the pathology outcome of kidney masses before surgery.
Key words: Kidney Neoplasms, Blood Platelets, Lymphocytes , Neutrophils
|
